Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    63,783.30
    -772.75 (-1.20%)
     

  • CMC Crypto 200

    1,327.34
    -69.19 (-4.95%)
     

  • S&P 500

    5,110.54
    +62.12 (+1.23%)
     

  • Dow

    38,302.31
    +216.51 (+0.57%)
     

  • Nasdaq

    15,962.64
    +350.88 (+2.25%)
     

  • Gold

    2,347.60
    +5.10 (+0.22%)
     

  • Crude Oil

    83.84
    +0.27 (+0.32%)
     

  • 10-Yr Bond

    4.6750
    -0.0310 (-0.66%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

New Strong Sell Stocks for March 6th

Zacks Equity Research
Updated

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Akorn, Inc. AKRX manufactures and markets diagnostic and therapeutic pharmaceuticals. The Zacks Consensus Estimate for its current year earnings has been revised 7.6% downward over the last 30 days.

Compass Diversified Holdings LLC CODI provides public investors with an opportunity to participate in the ownership and growth of companies. The Zacks Consensus Estimate for its current year earnings has been revised 3.6% downward over the last 30 days.

Eagle Pharmaceuticals, Inc. EGRX is a specialty pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 8.8% downward over the last 30 days.

ADVERTISEMENT

Impax Laboratories, Inc. IPXL is a specialty pharmaceutical company engaged in the development and marketing of bioequivalent pharmaceutical products. The Zacks Consensus Estimate for its current year earnings has been revised 18.1% downward over the last 30 days.

PRA Group, Inc. PRAA is a financial and business service company. The Zacks Consensus Estimate for its current year earnings has been revised 19.7% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Compass Diversified Holdings (CODI): Free Stock Analysis Report
 
Impax Laboratories, Inc. (IPXL): Free Stock Analysis Report
 
Akorn, Inc. (AKRX): Free Stock Analysis Report
 
PRA Group, Inc. (PRAA): Free Stock Analysis Report
 
Eagle Pharmaceuticals, Inc. (EGRX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research